Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion–related macular edema: A systematic review and meta-analysis of randomized controlled trials
This systematic review aimed to evaluate the effectiveness and safety of intravitreal dexamethasone (DEX) implant and intravitreal anti-vascular endothelial growth factor (VEGF) treatments for macular edema (ME) secondary to retinal vein occlusion (RVO), central retinal vein occlusion (CRVO), and br...
Main Authors: | Qiuming Hu, Haoyu Li, Wenhua Xu, Yi Du, Chao Ma, Jianfeng He |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Indian Journal of Ophthalmology |
Subjects: | |
Online Access: | http://www.ijo.in/article.asp?issn=0301-4738;year=2019;volume=67;issue=11;spage=1800;epage=1809;aulast=Hu |
Similar Items
-
Combined dexamethasone intravitreal implant (Ozurdex) and macular grid laser versus combined intravitreal bevacizumab and macular grid laser in branch retinal vein occlusion with macular edema
by: Abdelrahman G Salman
Published: (2015-01-01) -
Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
by: Frederic Matonti, et al.
Published: (2012-10-01) -
The efficacy of intravitreal dexamethasone implant as the first-line treatment for retinal vein occlusion-related macular edema in a real-life scenario
by: Mert Simsek, et al.
Published: (2018-01-01) -
Intravitreal dexamethasone implant Ozurdex® in naïve and refractory patients with different subtypes of diabetic macular edema
by: Verónica Castro-Navarro, et al.
Published: (2019-01-01) -
To study the effect of intravitreal ozurdex implant in cases of retinal vein occlusion
by: Shailender K Chaudhary, et al.
Published: (2022-01-01)